Cargando…

Alteration in gut mycobiota of patients with polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is a serious disease characterized by high androgen, insulin resistance (IR), hyperglycemia, and obesity, leading to infertility. The gut mycobiota has been reported to evolve in metabolic diseases including obesity, hyperglycemia, and fatty liver. However, little is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ke, Geng, Huafeng, Liu, Junbao, Ye, Cong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580825/ https://www.ncbi.nlm.nih.gov/pubmed/37702484 http://dx.doi.org/10.1128/spectrum.02360-23

Ejemplares similares

Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma
por: Zhang, Lilong, et al.
Publicado: (2023)

Alterations of Gut Mycobiota Profiles in Adenoma and Colorectal Cancer
por: Gao, Renyuan, et al.
Publicado: (2022)

Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity
por: Maeda, Yuichi, et al.
Publicado: (2022)

Description of Gut Mycobiota Composition and Diversity of Caprinae Animals
por: Lv, Qing-Bo, et al.
Publicado: (2023)

Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications
por: Sun, Yan, et al.
Publicado: (2023)

Association between Polycystic Ovary Syndrome and Gut Microbiota
por: Guo, Yanjie, et al.
Publicado: (2016)

The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome
por: Kelley, Scott T., et al.
Publicado: (2016)

Intersection of Polycystic Ovary Syndrome and the Gut Microbiome
por: Rizk, Maryan G, et al.
Publicado: (2020)

Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China
por: Li, Gailing, et al.
Publicado: (2022)

Polycystic Ovary Syndrome and Gut Microbiota: Phenotype Matters
por: Suturina, Larisa, et al.
Publicado: (2022)

Early gut mycobiota and mother-offspring transfer
por: Schei, Kasper, et al.
Publicado: (2017)

Depression in polycystic ovary syndrome: Focusing on pathogenesis and treatment
por: Xing, Liwei, et al.
Publicado: (2022)

Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota
por: Zhang, Mingmin, et al.
Publicado: (2022)

Immunophenotypic Profiles in Polycystic Ovary Syndrome
por: Hu, Cong, et al.
Publicado: (2020)

Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome
por: Li, Na, et al.
Publicado: (2021)

The gut mycobiota of rural and urban individuals is shaped by geography
por: Kabwe, Mubanga Hellen, et al.
Publicado: (2020)

Metagenomic-based characterization of the gut virome in patients with polycystic ovary syndrome
por: Huang, Liansha, et al.
Publicado: (2022)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
por: Boqun, Xu, et al.
Publicado: (2013)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
por: Wang, Fang, et al.
Publicado: (2012)

Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice
por: Zhang, Hong, et al.
Publicado: (2023)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Alterations of Sphingolipid Metabolism in Different Types of Polycystic Ovary Syndrome
por: Li, Juan, et al.
Publicado: (2019)

Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features
por: Lv, Longxian, et al.
Publicado: (2021)

Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment
por: Cao, Demin, et al.
Publicado: (2021)

Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome
por: Liu, Rui, et al.
Publicado: (2017)

Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome
por: Hassan, Saqib, et al.
Publicado: (2022)

Correction to: Early gut mycobiota and mother-offspring transfer
por: Schei, Kasper, et al.
Publicado: (2021)

Altered microRNAs expression profiling in cumulus cells from patients with polycystic ovary syndrome
por: Liu, Suying, et al.
Publicado: (2015)

Oral mycobiota and pancreatic ductal adenocarcinoma
por: Wei, Ailin, et al.
Publicado: (2022)

Psychological investigation in patients with polycystic ovary syndrome
por: Bazarganipour, Fatemeh, et al.
Publicado: (2013)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis
por: Li, Pan, et al.
Publicado: (2023)

The alterations of circulating mucosal-associated invariant T cells in polycystic ovary syndrome
por: Zhou, Hong, et al.
Publicado: (2022)

Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome
por: Kokosar, Milana, et al.
Publicado: (2016)

Physical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary Syndrome
por: Simmonds, Michael J., et al.
Publicado: (2016)

Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1(†)
por: Khatun, Masuma, et al.
Publicado: (2020)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_en7gtum8t2lj1uh0ch97u6vdpn